Dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), arrhythmic cardiomyopathy (ACM), and other hereditary or unclassified cardiomyopathies
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Comply with the definitions of international/domestic guidelines related to cardiomyopathy, complete CMR examination, sign the informed consent form (prospective), and obtain ethical approval from the center
Exclusion criteria
Exclusion criteria: 1. Refusing to use their personal clinical data, imaging materials and biological samples; 2. Incomplete clinical data, making it impossible to complete at least 5-year follow-up; 3. The CMR image quality does not meet the research quality control requirements and cannot be re-examined; 4. There are absolute contraindications for CMR examination, including but not limited to: having electronic devices implanted in the body (such as pacemakers, implantable cardioverter defibrillators (ICDs), nerve stimulators, etc.), having metal foreign bodies in the body (such as metal foreign bodies in the eyeball, unremoved shrapids, etc.), and having claudephobia and being unable to cooperate to complete the CMR examination. 5. Those with severe coagulation dysfunction, bleeding tendency, or inability to cooperate in completing peripheral blood collection; 6. Those who the researcher believes are not suitable to participate in this study due to other health conditions, cognitive abilities or objective conditions, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical data (demographic information, chief complaint duration, medical history, laboratory parameters, etc.);Cardiac Magnetic Resonance (CMR) imaging data (cine, T1/T2 mapping, LGE, DICOM files, and structured reports);Safety outcomes (including claustrophobia, noise and positional discomfort, serious adverse events (SAEs)); | — |
Countries
China
Contacts
West China Hospital of Sichuan University